Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: A population of 10776 close contacts in the epidemic of Fujian.

Authors:
Zeng Y; Lin C; Liu C; Huang C; Chen F and 19 more

Journal:
Clin Chim Acta

Publication Year: 2022

DOI:
10.1016/j.cca.2022.12.017

PMCID:
PMC9783188

PMID:
36572136

Journal Information

Full Title: Clin Chim Acta

Abbreviation: Clin Chim Acta

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Chemistry, Clinical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"appendix a supplementary data the following are the supplementary data to this article: supplementary data 1 data availability the data that has been used is confidential."

Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"The authors thank all health care workers in fighting against this epidemic for their collecting data and samples. The authors thank Wantai Bio., Lizhu Bio., Yahuilong Bio., and Dongfang Bio. for providing anti-SARS-CoV-2 antibodies testing reagents. This work was supported by the National Natural Science Foundation of China."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025